These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19801974)

  • 1. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer.
    Gumireddy K; Li A; Gimotty PA; Klein-Szanto AJ; Showe LC; Katsaros D; Coukos G; Zhang L; Huang Q
    Nat Cell Biol; 2009 Nov; 11(11):1297-304. PubMed ID: 19801974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.
    Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A
    J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells.
    Ali A; Shah AS; Ahmad A
    Cancer Lett; 2014 Nov; 354(1):87-96. PubMed ID: 25111898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression.
    Ismail IA; Kang HS; Lee HJ; Kim JK; Hong SH
    Br J Cancer; 2014 Mar; 110(5):1298-306. PubMed ID: 24504364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
    Ye WC; Gao L; Huang J; Fang XM; Xie G
    Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
    Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
    Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis.
    Zhou S; Tang X; Tang F
    Tumour Biol; 2016 Feb; 37(2):1505-13. PubMed ID: 26662959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of metastatic [Id]entity by KLF17.
    Iwanicki MP; Brugge JS
    Genome Biol; 2009; 10(11):244. PubMed ID: 19951400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
    Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
    Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
    Ismail IA; Kang HS; Lee HJ; Chang H; Yun J; Lee CW; Kim NH; Kim HS; Yook JI; Hong SH; Kwon BM
    Breast Cancer Res Treat; 2013 Feb; 137(3):697-708. PubMed ID: 23283523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
    Yang J; Mani SA; Donaher JL; Ramaswamy S; Itzykson RA; Come C; Savagner P; Gitelman I; Richardson A; Weinberg RA
    Cell; 2004 Jun; 117(7):927-39. PubMed ID: 15210113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of KLF17 is associated with tumor invasion in esophageal carcinoma.
    Li S; Qin X; Cui A; Wu W; Ren L; Wang X
    Int J Clin Exp Pathol; 2015; 8(9):11157-63. PubMed ID: 26617836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
    Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J
    Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
    Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
    J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer.
    DiMeo TA; Anderson K; Phadke P; Fan C; Perou CM; Naber S; Kuperwasser C
    Cancer Res; 2009 Jul; 69(13):5364-73. PubMed ID: 19549913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
    Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
    Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.
    Dong P; Kaneuchi M; Xiong Y; Cao L; Cai M; Liu X; Guo SW; Ju J; Jia N; Konno Y; Watari H; Hosaka M; Sudo S; Sakuragi N
    Carcinogenesis; 2014 Apr; 35(4):760-8. PubMed ID: 24220291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
    Liu X; Feng R
    Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):496-501. PubMed ID: 20705589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
    Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.